• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A retrospective analysis of clinical characteristics and outcomes of pediatric fulminant myocarditis.回顾性分析小儿暴发性心肌炎的临床特征及转归。
BMC Pediatr. 2024 Aug 29;24(1):553. doi: 10.1186/s12887-024-05022-4.
2
Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis.分析临床参数和心脏磁共振成像作为小儿心肌炎预后的预测指标。
Am J Cardiol. 2015 Feb 15;115(4):499-504. doi: 10.1016/j.amjcard.2014.11.029. Epub 2014 Nov 29.
3
Management and outcomes in pediatric patients presenting with acute fulminant myocarditis.儿科暴发性心肌炎患者的管理和结局。
J Pediatr. 2011 Apr;158(4):638-643.e1. doi: 10.1016/j.jpeds.2010.10.015. Epub 2010 Dec 30.
4
Short-term outcomes of acute fulminant myocarditis in children.儿童急性暴发性心肌炎的短期预后
Pediatr Cardiol. 2011 Oct;32(7):885-90. doi: 10.1007/s00246-011-0007-8. Epub 2011 May 17.
5
Risk Factors for Cardiac Arrest or Mechanical Circulatory Support in Children with Fulminant Myocarditis.暴发性心肌炎患儿发生心脏骤停或机械循环支持的危险因素
Pediatr Cardiol. 2017 Jan;38(1):128-134. doi: 10.1007/s00246-016-1493-5. Epub 2016 Nov 8.
6
Impact of Extracorporeal Membrane Oxygenation on Acute Fulminant Myocarditis-related Hemodynamic Compromise Arrhythmia in Children.体外膜肺氧合对儿童暴发性心肌炎相关血流动力学障碍心律失常的影响。
Pediatr Neonatol. 2016 Dec;57(6):480-487. doi: 10.1016/j.pedneo.2016.02.002. Epub 2016 Mar 16.
7
Influence of echocardiographic measurements and renal impairments on the prognosis of fulminant myocarditis.超声心动图测量及肾功能损害对暴发性心肌炎预后的影响
Medicine (Baltimore). 2018 Feb;97(5):e9812. doi: 10.1097/MD.0000000000009812.
8
[Clinical features and outcomes of pediatric acute fulminant myocarditis requiring extracorporeal membrane oxygenation].[需要体外膜肺氧合的小儿急性暴发性心肌炎的临床特征及预后]
Zhonghua Yi Xue Za Zhi. 2019 Dec 17;99(47):3715-3719. doi: 10.3760/cma.j.issn.0376-2491.2019.47.008.
9
Are clinical features and cardiac biomarkers at admission related to severity in pediatric acute myocarditis?: Clinical features and cardiac biomarkers in pediatric acute myocarditis.入院时的临床特征和心脏生物标志物与儿科急性心肌炎的严重程度有关吗?:儿科急性心肌炎的临床特征和心脏生物标志物。
Arch Pediatr. 2022 Jul;29(5):376-380. doi: 10.1016/j.arcped.2022.03.008. Epub 2022 May 27.
10
[Prognostic value of left ventricular ejection fraction on admission in patients with septic cardiomyopathy].[入院时左心室射血分数对脓毒症心肌病患者的预后价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Aug;35(8):839-843. doi: 10.3760/cma.j.cn121430-20230407-00253.

引用本文的文献

1
Beyond the consult: Outcomes following pediatric VAD referral.咨询之外:儿科心室辅助装置转诊后的结果
JHLT Open. 2025 Jun 20;9:100318. doi: 10.1016/j.jhlto.2025.100318. eCollection 2025 Aug.
2
New Systemic Inflammatory Indices as Predictors of Fulminant Myocarditis in Children.作为儿童暴发性心肌炎预测指标的新全身炎症指数
Diagnostics (Basel). 2025 Apr 10;15(8):961. doi: 10.3390/diagnostics15080961.
3
Outbreak of Acute Fulminant Myocarditis in Children in Campania Region, Italy: A Case Series.意大利坎帕尼亚地区儿童急性暴发性心肌炎疫情:病例系列
Children (Basel). 2024 Nov 23;11(12):1414. doi: 10.3390/children11121414.

本文引用的文献

1
SARS-CoV-2 Related Myocarditis: What We Know So Far.新型冠状病毒2型相关心肌炎:目前我们所了解的情况。
J Clin Med. 2023 Jul 15;12(14):4700. doi: 10.3390/jcm12144700.
2
Clinical characteristics and mortality risk prediction model in children with acute myocarditis.儿童急性心肌炎的临床特征和死亡风险预测模型。
World J Pediatr. 2023 Feb;19(2):180-188. doi: 10.1007/s12519-022-00637-y. Epub 2022 Nov 15.
3
Clinical and electrocardiographic characteristics in patients with fulminant myocarditis.暴发性心肌炎患者的临床和心电图特征
J Arrhythm. 2022 Jul 8;38(5):763-771. doi: 10.1002/joa3.12751. eCollection 2022 Oct.
4
Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study.静脉-静脉体外膜肺氧合在急性 COVID-19 相关呼吸衰竭患者中的应用:比较有效性研究。
BMJ. 2022 May 4;377:e068723. doi: 10.1136/bmj-2021-068723.
5
Efficacy of a temporary CentriMag ventricular assist device in acute fulminant myocarditis patients revived with extracorporeal cardiopulmonary resuscitation.体外心肺复苏后使用临时 CentriMag 心室辅助装置治疗暴发性心肌炎患者的疗效。
J Formos Med Assoc. 2022 Oct;121(10):1917-1928. doi: 10.1016/j.jfma.2022.01.018. Epub 2022 Feb 17.
6
Pediatric Fulminant Myocarditis in Japan: A Retrospective Nationwide Database Study of Hospital Volume, Management Practices, and Mortality.日本小儿暴发性心肌炎:一项回顾性全国医院数据库研究,内容涉及医院容量、管理实践和死亡率。
Pediatr Crit Care Med. 2021 Jul 1;22(7):e391-e401. doi: 10.1097/PCC.0000000000002692.
7
Intravenous Immunoglobulin Therapy in Myocarditis.心肌炎的静脉注射免疫球蛋白治疗。
Iran J Allergy Asthma Immunol. 2020 Aug 25;19(4):323-336. doi: 10.18502/ijaai.v19i4.4109.
8
Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes.暴发性心肌炎:从病因到治疗和结局的全面综述。
Signal Transduct Target Ther. 2020 Dec 11;5(1):287. doi: 10.1038/s41392-020-00360-y.
9
Acute Myocarditis in Children: a 10-year Nationwide Study (2007-2016) based on the Health Insurance Review and Assessment Service Database in Korea.儿童急性心肌炎:基于韩国健康保险审查与评估服务数据库的10年全国性研究(2007 - 2016年)
Korean Circ J. 2020 Nov;50(11):1013-1022. doi: 10.4070/kcj.2020.0108. Epub 2020 Aug 7.
10
Total percutaneous biventricular assist device implantation for fulminant myocarditis.经皮全心室辅助装置植入术治疗暴发性心肌炎。
J Artif Organs. 2021 Jun;24(2):254-257. doi: 10.1007/s10047-020-01197-6. Epub 2020 Aug 4.

回顾性分析小儿暴发性心肌炎的临床特征及转归。

A retrospective analysis of clinical characteristics and outcomes of pediatric fulminant myocarditis.

机构信息

Nanjing Medical University Affiliated Nanjing Children's Hospital, Nanjing, 210008, China.

出版信息

BMC Pediatr. 2024 Aug 29;24(1):553. doi: 10.1186/s12887-024-05022-4.

DOI:10.1186/s12887-024-05022-4
PMID:39210278
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11360287/
Abstract

BACKGROUND

The study aimed to explore clinical indicators that can predict the prognosis of children with acute fulminant myocarditis (AFM) through a retrospective analysis.

METHODS

A retrospective analysis was conducted on the clinical indices of 79 children diagnosed with AFM and hospitalized from March 2013 to March 2023. Relevant demographic and clinical data, including symptoms at admission, laboratory results, and outcomes were extracted to identify factors associated with in-hospital mortality.

RESULTS

A total of 79 children with AFM were analyzed. The survival group (n = 61) had a longer median hospital stay and higher medical expenses compared to the death group (n = 18). Significant differences in the levels of left ventricular ejection fraction (LVEF)(P < 0.001), myoglobin (MYO)(P < 0.001), aspartate aminotransferase (AST)(P < 0.001), lactate dehydrogenase (LDH)(P = 0.004), B-type natriuretic peptide (BNP)(P = 0.005), arterial potential hydrogen (PH)(P < 0.001), bicarbonate (HCO)(P = 0.003), serum lactate (Lac)(P = 0.001), peripheral oxygen saturation (SpO)(P = 0.008), and white blood cell count (WBC)(P = 0.007) were observed between the two groups. Additionally, there were significant differences in the incidences of multi-organ failure (P = 0.003) and respiratory failure (P = 0.001) between the two groups.

CONCLUSIONS

Severe myocardial injury (AST > 194.00 U/L, LDH > 637.50 U/L, MYO > 265.75 µg/L, BNP > 1738.50 ng/L), acidosis (PH < 7.29, HCO <18.45 mmol/L, Lac > 12.30 mmol/L), hypoxia (SpO < 97.50%), inflammatory response (WBC > 9.69*10/L), left ventricular systolic dysfunction (LVEF < 28.25%), multi-organ failure, and respiratory failure are significantly associated with higher mortality rates. These factors can accurately identify AFM children at an increased risk of death.

摘要

背景

本研究通过回顾性分析,旨在探讨能够预测儿童暴发性心肌炎(AFM)预后的临床指标。

方法

对 2013 年 3 月至 2023 年 3 月期间诊断为 AFM 并住院的 79 例儿童的临床指标进行回顾性分析。提取相关人口统计学和临床数据,包括入院时的症状、实验室结果和结局,以确定与院内死亡率相关的因素。

结果

共分析了 79 例 AFM 患儿。与死亡组(n=18)相比,存活组(n=61)的中位住院时间更长,医疗费用更高。两组间左心室射血分数(LVEF)(P<0.001)、肌红蛋白(MYO)(P<0.001)、天门冬氨酸氨基转移酶(AST)(P<0.001)、乳酸脱氢酶(LDH)(P=0.004)、B 型利钠肽(BNP)(P=0.005)、动脉氢离子浓度(PH)(P<0.001)、碳酸氢盐(HCO)(P=0.003)、血清乳酸(Lac)(P=0.001)、外周血氧饱和度(SpO)(P=0.008)和白细胞计数(WBC)(P=0.007)水平存在显著差异。此外,两组间多器官功能衰竭(P=0.003)和呼吸衰竭(P=0.001)的发生率也存在显著差异。

结论

严重心肌损伤(AST>194.00 U/L、LDH>637.50 U/L、MYO>265.75 µg/L、BNP>1738.50 ng/L)、酸中毒(PH<7.29、HCO<18.45 mmol/L、Lac>12.30 mmol/L)、缺氧(SpO<97.50%)、炎症反应(WBC>9.69*10/L)、左心室收缩功能障碍(LVEF<28.25%)、多器官功能衰竭和呼吸衰竭与较高的死亡率显著相关。这些因素可以准确识别出 AFM 患儿死亡风险增加的情况。